AXON - Axovant Sciences Ltd.

NasdaqGS - NasdaqGS Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue---
Cost of Revenue---
Gross Profit---
Operating Expenses
Research Development134,77876,64414,324.314
Selling General and Administrative45,72156,5186,721.737
Non Recurring---
Total Operating Expenses---
Operating Income or Loss-180,499-133,162-21,046.051
Income from Continuing Operations
Total Other Income/Expenses Net-369-369-369
Earnings Before Interest and Taxes-180,868-133,162-21,046.051
Interest Expense1,1431,1431,143
Income Before Tax-182,011-133,162-21,046.051
Income Tax Expense-1,060-170.968
Minority Interest---
Net Income From Continuing Ops-180,951-133,145-21,047.019
Non-recurring Events
Discontinued Operations---
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income-180,951-133,145-21,047.019
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares-180,951-133,145-21,047.019